Evolutionary epidemiology 20 years on: Challenges and prospects

Infection, Genetics and Evolution

Volumn 9, Issue 1, 2009, Pages 108-123

  Restif, Olivier ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Epidemiology; Infectious diseases; Pathogens; Vaccine; Virulence

Indexed keywords

ADAMANTANE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; HEAT SHOCK PROTEIN 90; HEPATITIS B VACCINE; INFLUENZA VACCINE; OSELTAMIVIR;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL RESISTANCE; ANTIGENIC VARIATION; ANTIVIRAL RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; CONCEPTUAL FRAMEWORK; DRUG DESIGN; ECOLOGY; EVOLUTION; FUNGAL VIRULENCE; GENETIC CONSERVATION; GENETIC VARIABILITY; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INNATE IMMUNITY; MALARIA FALCIPARUM; MATHEMATICAL MODEL; MOLECULAR BIOLOGY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PARASITE VIRULENCE; PATIENT COMPLIANCE; PHENOTYPIC VARIATION; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; VIRUS VIRULENCE;

EID: 57549094802     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2008.09.007     Document Type: Note

References (308)

1. Abu-Raddad L.J., and Ferguson N.M. The impact of cross-immunity, mutation and stochastic extinction on pathogen diversity. Proc. R. Soc. Lond. B 271 (2004) 2431-2438
2. Aiello A.E., and Larson E. Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. Lancet Infect. Dis. 3 (2003) 501-506
3. Akileswaran C., Lurie M.N., Flanigan T.P., and Mayer K.H. Lessons learned from use of highly active antiretroviral therapy in Africa. Clin. Infect. Dis. 41 (2005) 376-385
4. Alexander M.E., Bowman C.S., Feng Z., Gardam M., Moghadas S.M., Röst G., Wu J., and Yan P. Emergence of drug resistance: implications for antiviral control of pandemic influenza. Proc. R. Soc. Lond. B 274 (2007) 1675-1684
5. Alexandersen S., Quan M., Murphy C., Knight J., and Zhang Z. Studies of quantitative parameters of virus excretion and transmission in pigs and cattle experimentally infected with foot-and-mouth disease virus. J. Comp. Pathol. 129 (2003) 268-282
6. Alisky J., Iczkowski K., Rapoport A., and Troitsky N. Bacteriophages show promise as antimicrobial agents. J. Infect. 36 (1998) 5-15
7. Alizon S. Transmission-recovery trade-offs to study parasite evolution. Am. Nat. 172 (2008) E113-E121
8. Alizon S., and Van Baalen M. Emergence of a convex trade-off between transmission and virulence. Am. Nat. 165 (2005) E155-167
9. Allison A.C. Protection afforded by sickle-cell trait against subtertian malarial infection. Br. Med. J. 6 (1954) 290-294
10. Aminov R.I., and Mackie R.I. Evolution and ecology of antibiotic resistance genes. FEMS Microbiol. Lett. 271 (2007) 147-161
11. Anderson R.M., and May R.M. Coevolution of hosts and parasites. Parasitology 85 (1982) 411-426
12. André J.-B., and Day T. The effect of disease life history on the evolutionary emergence of novel pathogens. Proc. R. Soc. Lond. B 272 (2005) 1949-1956
13. André J.-B., Ferdy J.-B., and Godelle B. Within-host parasite dynamics, emerging trade-off, and evolution of virulence with immune system. Evolution 57 (2003) 1489-1497
14. André J.-B., and Hochberg M.E. Virulence evolution in emerging infectious diseases. Evolution 59 (2005) 1406-1412
15. Antia R., and Lipsitch M. Mathematical models of parasite responses to host immune defences. Parasitology 115 Supplement (1997) S155-S167
16. Antia R., Regoes R.R., Koella J.C., and Bergstrom C.T. The role of evolution in the emergence of infectious diseases. Nature 426 (2003) 658-661
17. Antonovics J., Abbate J.L., Baker C.H., Daley D., Hood M.E., Jenkins C.E., Johnson L.J., Murray J.J., Panjeti V., Rudolf V.H.W., Sloan D., and Vondrasek J. Evolution by any other name: antibiotic resistance and avoidance of the e-word. PLoS Biol. 5 (2007) e30
18. Ariën K.K., Troyer M.M., Gali Y., Colebunders R.L., Arts E.J., and Vanham G. Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19 (2005) 1555-1564
19. Ariën K.K., Vanham G., and Arts E.J. Is HIV-1 evolving to a less virulent form in humans?. Nat. Rev. Microbiol. 5 (2007) 141-151
20. Arnaud F., Caporale M., Varela M., Biek R., Chessa B., Alberti A., Golder M., Mura M., zhang Y.-P., Yu L., Pereira F., DeMartini J.C., Leymaster K., Spencer T.E., and Palmarini M. A paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses. PLoS Pathog. 3 (2007) e170
21. Asquith B., Edwards C.T.T., Lipsitch M., and McLean A.R. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 4 (2006) e90
22. + T cell control of immunodeficiency virus infection in humans and macaques. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 6365-6370
23. Balaban N.Q., Merrin J., Chait R., Kowalik L., and Leibler S. Bacterial persistence as a phenotypic switch. Science 305 (2004) 1622-1625
24. Balkissoon D., Staines K., McCauley J., Wood J.L.N., Young J., Kaufman J., and Butter C. Low frequency of the Mx allele for viral resistance predates recent intensive selection in domestic chickens. Immunogenetics 59 (2007) 687-691
25. Ball G.H. Parasitism and evolution. Am. Nat. 77 (1943) 345-364
26. Bangsberg D.R. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J. Infect. Dis. 197 Suppl. 3 (2008) S272-S278
27. Barlow G., and Nathwani D. Is antibiotic resistance a problem? A practical guide for hospital clinicians. Postgrad. Med. J. 81 (2005) 680-692
28. Barrett J.F. Can biotech deliver new antibiotics?. Curr. Opin. Microbiol. 8 (2005) 498-503
29. Becker D., Selbach M., Rollenhagen C., Ballmaier M., Meyer T.F., Mann M., and Bumann D. Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 440 (2006) 303-307
30. Bell G., and Gouyon P.-H. Arming the enemy: the evolution of resistance to self-proteins. Microbiology 149 (2003) 1367-1375
31. Benfield C.T.O., Lyall J.W., Kochs G., and Tiley L.S. Asparagine 631 variants of the chicken Mx protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in vitro surrogate assays. J. Virol. 82 (2008) 7533-7539
32. Bertagnolio S., Derdelinkx I., Parker M., Fitzgibbon J., Fleury H., Peeters M., Schuurman R., Pillay D., Morris L., Tanuri A., Gershy-Damet G.-M., Nkengasong J., Gilks C.F., Sutherland D., and Sandstrom P. World Health Organization/HIVResNet drug resistance laboratory strategy. Antivir. Ther. 13 Suppl. 2 (2008) 49-57
33. Best S., Le Tissier P.R., and Stoye J.P. Endogenous retroviruses and the evolution of resistance to retroviral infection. Trends Microbiol. 5 (1997) 313-318
34. Birrer M.J., Udem S., Nathenson S., and Bloom B.R. Antigenic variants of measles virus. Nature 293 (1981) 67-69
35. Bjarnsholt T., and Givskov M. Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Philos. Trans. R. Soc. Lond. B 362 (2007) 1213-1222
36. Björkman A., and Bhattarai A. Public health impact of drug resistant Plasmodium falciparum malaria. Acta Trop. 94 (2005) 163-169
37. Blankenship J.R., and Mitchell A.P. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 9 (2006) 588-594
38. Boirivant M., and Strober W. The mechanism of action of probiotics. Curr. Opin. Gastroenterol. 23 (2007) 679-692
39. Bonhoeffer S., May R.M., Shaw G.M., and Nowak M.A. Virus dynamics and drug therapy. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6971-6976
40. Boni M.F., Gog J.R., Andreasen V., and Feldman M.W. Epidemic dynamics and antigenic evolution in a single season of influenza A. Proc. R. Soc. Lond. B 273 (2006) 1307-1316
41. Boots M., Hudson P.J., and Sasaki A. Large shifts in pathogen virulence relate to host population structure. Science 303 (2004) 842-844
42. Bremermann H.J., and Pickering J. A game-theoretical model of parasite virulence. J. Theor. Biol. 100 (1983) 411-426
43. Brown S.P., Cornell S.J., Sheppard M., Grant A.J., Maskell D.J., Grenfell B.T., and Mastroeni P. Intracellular demography and the dynamics of Salmonella enterica infections. PLoS Biol. 4 (2006) e349
44. Brown S.P., Le Chat L., De Paepe M., and Taddei F. Ecology of microbial invasions: amplification allows virus carriers to invade more rapidly when rare. Curr. Biol. 16 (2006) 2048-2052
45. Brown S.P., Le Chat L., and Taddei F. Evolution of virulence: triggering host inflammation allows invading pathogens to exclude competitors. Ecol. Lett. 11 (2008) 44-51
46. Buckling A., and Rainey P.B. Antagonistic coevolution between a bacterium and a bacteriophage. Proc. R. Soc. Lond. B 269 (2002) 931-936
47. Cannon R.D., Lamping E., Holmes A.R., Niimi K., Tanabe K., Niimi M., and Monk B.C. Candida albicans drug resistance-another way to cope with stress. Microbiology 153 (2007) 3211-3217
48. Capparelli R., Parlato M., Borriello G., Salvatore P., and Iannelli D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob. Agents Chemother. 51 (2007) 2765-2773
49. Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., Zuckerman A.J., and Thomas H.C. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336 (1990) 325-329
50. Centers for Disease Control and Prevention, 2008. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. Morb. Mortal. Wkly. Rep. 57, 144-148.
51. Chait R., Craney A., and Kishony R. Antibiotic interactions that select against resistance. Nature 446 (2007) 668-671
52. Chevillon C., Briant L., Renaud F., and Devaux C. The Chikungunya threat: an ecological and evolutionary perspective. Trends Microbiol. 16 (2008) 80-88
53. Cholera R., Brittain N.J., Gillrie M.R., Lopera-Mesa T.M., Diakité S.A.S., Arie T., Krause M.A., Guindo A.B., Tubman A., Fujioka H., Diallo D.A., Doumbo O.K., Ho M., Wellems T.E., and Fairhurst R.M. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 991-996
54. Cirz R.T., Chin J.K., Andes D.R., de Crécy-Lagard V., Craig W.A., and Romesberg F.E. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3 (2005) e176
55. Clutton-Brock T.H., and Harvey P.H. Comparison and adaptation. Proc. R. Soc. Lond. B 205 (1979) 547-565
56. Coffey, L.L., Vasilakis, N., Brault, A.C., Powers, A.M., Tripet, F., Weaver, S.C., 2008. Arbovirus evolution in vivo is constrained by host alternation. Proc. Natl. Acad. Sci. U.S.A. 105, 6970-6975.
57. Colbère-Garapin F., Martin-Latil S., Blondel B., Mousson L., Pelletier I., Autret A., Francois A., Niborski V., Grompone G., Catonnet G., and van de Moer A. Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria. Microbes Infect. 9 (2007) 14-15
58. Conenello G.M., Zamarin D., Perrone L.A., Tumpey T.M., and Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3 (2007) e141
59. Connolly L.E., Edelstein P.H., and Ramakrishnan L. Why is long-term therapy required to cure tuberculosis?. PLoS Med. 4 (2007) e120
60. Cooper B.S., Medley G.F., Stone S.P., Kibbler C.C., cookson B.D., Roberts J.A., Duckworth G., Lai R., and Ebrahim S. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10223-10228
61. Corr S.C., Li Y., Riedel C.U., O'Toole P.W., Hill C., and Gahan C. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 7617-7621
62. Costagliola D., Descamps D., Assoumou L., Morand-Joubert L., Marcelin A., Brodard V., Delauguerre C., Mackiewicz V., Ruffault A., Izopet J., Plantier J.C., Tamalet C., Yerly S., Saidi S., Brun-Vezinet F., and Masquelier B. Prevalence of HIV-1 drug resistance in treated patients: a French Nationwide Study. J. Acquir. Immune Defic. Syndr. 46 (2007) 12-18
63. Cotton, M.F., Wasserman, E., Smit, J., Whitelaw, A., Zar, H.J., 2008. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMC Infect. Dis. 8, 40.
64. Cowen L.E. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat. Rev. Microbiol. 6 (2008) 187-198
65. Crawford H., Prado J.G., Leslie A., Hué S., Honeyborne I., Reddy S., van der Stok M., Mncumbe Z., Brander C., Rousseau C., Mullins J.I., Kaslow R., Goepfert P., Allen S., Hunter E., Mulenga J., Kiepiela P., Walker B.D., and Goulder P.J.R. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 81 (2007) 8346-8351
66. Dagan R., Barkai G., Givon-Lavi N., Sharf A.Z., Vardy D., Cohen T., Lipsitch M., and Greenberg D. Seasonality of antibiotic-resistant Streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?. J. Infect. Dis. 197 (2008) 1094-1102
67. Dantas G., Sommer M.O.A., Oluwasegun R.D., and Church G.M. Bacteria subsisting on antibiotics. Science 320 (2008) 100-103
68. Day T., André J.-B., and Park A.W. The evolutionary emergence of pandemic influenza. Proc. R. Soc. Lond. B 273 (2006) 2945-2953
69. Day T., and Gandon S. Applying population-genetic models in theoretical evolutionary epidemiology. Ecol. Lett. 10 (2007) 876-888
70. Day T., and Proulx S.S. A general theory for the evolutionary dynamics of virulence. Am. Nat. 163 (2004) E40-E63
71. De Jong M.D., Thanh T.T., Khanh T.H., Hien V.M., Smith G.J.D., Nguyen V.C., Bach T.Q., Phan T.Q., Do Q.H., Guan Y., Peiris J.S., Tran T.H., and Farrar J. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353 (2005) 2667-2672
72. de Meeus T., McCoy K.D., Prugnolle F., Chevillon C., Durand P., Hurtrez-Boussès S., and Renaud F. Population genetics and molecular epidemiology or how to "débusquer la bête. Infect. Genet. Evol. 7 (2007) 308-332
73. de Roode J.C., Helinski M.E.H., Anwar M.A., and Read A.F. Dynamics of multiple infection and within-host competition in genetically diverse malaria infections. Am. Nat. 166 (2005) 531-542
74. De Roode J.C., Pansini R., Cheesman S.J., Helinski M.E.H., Huijben S., Wargo A.R., Bell A.S., Chan B.H.K., Walliker D., and Read A.F. Virulence and competitive ability in genetically diverse malaria infections. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 7624-7628
75. De Roode, J.C., Yates, A.J., Altizer, S., 2008. Virulence-transmission trade-offs and population divergence in virulence in a naturally occurring butterfly parasite. Proc. Natl. Acad. Sci. U.S.A. 105, 7489-7494.
76. Dethlefsen L., McFall-Ngai M., and Relman D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449 (2007) 811-818
77. Deyde V.M., Xu X., Bright R.A., Shaw M., Smith C.B., Zhang Y., Shu Y., Gubareva L.V., Cox N.J., and Klimov A.I. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J. Infect. Dis. 196 (2007) 249-257
78. Dieckmann U., Metz J.A.J., Sabelis M.W., and Sigmund K. Adaptive dynamics of infectious diseases. In pursuit of virulence management. Cambridge Studies in Adaptive Dynamics (2002)
79. Diep B.A., Carleton H.A., Chang R.F., Sensabaugh G.F., and Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 193 (2007) 1495-1503
80. Donald A.D. Parasites, animal production and sustainable development. Vet. Parasitol. 54 (1994) 27-47
81. Donlan R.M. Biofilm formation: a clinically relevant microbiological process. Clin. Infect. Dis. 33 (2001) 1387-1392
82. Dowdeswell G.F. On the infectivity of the blood and other fluids in some forms of septic disease, and the reputed occurrence therein of an increase of virulence in successive inoculations. Proc. R. Soc. Lond. B 34 (1883) 449-469
83. Dugatkin L.A., Perlin M., Lucas J.S., and Atlas R. Group-beneficial traits, frequency-dependent selection and genotypic diversity: an antibiotic resistance paradigm. Proc. R. Soc. Lond. B 272 (2005) 79-83
84. Dupuy B., and Sonenshein A.L. Regulated transcription of Clostridium difficile toxin genes. Mol. Microbiol. 27 (1998) 107-120
85. Ebert D. Experimental evolution of parasites. Science 282 (1998) 1432-1435
86. Ebert D. Virulence and local adaptation of a horizontally transmitted parasite. Science 265 (1994) 1084-1086
87. Ebert D., and Bull J.J. Challenging the trade-off model for the evolution of virulence. Trends Microbiol. 11 (2003) 15-20
88. Ebert D., and Mangin K.L. The influence of host demography on the evolution of virulence of a microsporidian gut parasite. Evolution 51 (1997) 1828-1837
89. Edelman R. Dengue vaccines approach the finish line. Clin. Infect. Dis. 1 Suppl. 45 (2007) S56-S60
90. Egan T.J., and Kaschula C.H. Strategies to reverse drug resistance in malaria. Curr. Opin. Infect. Dis. 20 (2007) 598-604
91. Ekland E.H., and Fidock D.A. Advances in understanding the genetic basis of antimalarial drug resistance. Curr. Opin. Microbiol. 10 (2007) 363-370
92. Elliot S.L. The virulence-transmission trade-off and virulence management. Trends Microbiol. 11 (2003) 205-206
93. Elliot, S.L., Sabelis, M.W., Adler, F.R., 2002. Virulence management in biocontrol agents. In: Dieckmann, U., Metz, J.A.J., Sabelis, M.W. and Sigmund, K. (Eds.), Adaptive Dynamics of Infectious Diseases. In Pursuit of virulence Management. Cambridge University Press.
94. Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundman H., and Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 7687-7692
95. Escorcia, M., Vazquez, L., Mendez, S.T., Rodriguez-Ropon, A., Lucio, E., Nava, G.M., 2008. Avian influenza: genetic evolution under vaccination pressure. Virol. J. 5, 15.
96. European Centre for Disease Prevention and Control, 2008. Antivirals and Antiviral Resistance Influenza.
97. Ewald P.W. Cultural vectors, virulence and the emergence of evolutionary epidemiology. In: Harvey P.H., and Partridge L. (Eds). Oxford Surveys in Evolutionary Biology vol. 5 (1988), Oxford University Press
98. Ewald P.W. Evolution of Infectious Disease (1994), Oxford University Press
99. Ewald P.W. Guarding against the most dangerous emerging pathogens: insights from evolutionary biology. Emerg. Infect. Dis. 2 (1996) 245-257
100. Farr B.M., Salgado C.D., Karchmer T.B., and Sherentz R.J. Can antibiotic-resistant nosocomial infections be controlled?. Lancet Infect. Dis. 1 (2001) 38-45
101. Feld, L., Schjorring, S., Hammer, K., Licht, T.R., Danielsen, M., Krogfelt, K., Wilcks, A., 2008. Selective pressure affects transfer and establishment of a Lactobacillus plantarum resistance plasmid in the gastrointestinal environment. J. Antimicrob. Chemother. 61, 4.
102. Fenner F. The Florey lecture, Biological control, as exemplified by smallpox eradication and myxomatosis. Proc. R. Soc. Lond. B 218 (1983) 259-285
103. Ferguson N.M., Galvani A.P., and Bush R.M. Ecological and immunological determinants of influenza evolution. Nature 422 (2003) 428-433
104. Fernandez C.S., Smith M.Z., Batten C.J., De Rose R., Reece J.C., Rollman E., Venturi V., Davenport M.P., and Kent S.J. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants. J. Virol. 81 (2007) 4137-4144
105. Finch R.G., Metlay J.P., Davey P.G., and Baker L.J. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect. Dis. 4 (2004) 44-53
106. Fine P.E.M. John Brownlee and the measurement of infectiousness: an historical study in epidemic theory. J. R. Stat. Soc. A 142 (1979) 347-362
107. Fitch W.M., Bush R.M., Bender C.A., and Cox N.J. Long term trends in the evolution of H(3) HA1 human influenza type A. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7712-7718
108. Foreman-Wykert A.F., and Miller J.F. Hypervirulence and pathogen fitness. Trends Microbiol. 11 (2003) 105-108
109. Foster, G.L., Barr, T.A., Grant, A.J., McKinley, T.J., Bryant, C.E., MacDonald, A., Gray, D., Yamamoto, M., Akira, S., Maskell, D.J., Mastroeni, P., 2008. Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88. Immunology 124, 469-479.
110. +-thalassaemia contributes to protection against severe malarial anaemia. PLoS Med. 5 (2008) e56
111. Frank S.A. Models of parasite virulence. Q. Rev. Biol. 71 (1996) 37-78
112. Frank S.A., and Barbour A.G. Within-host dynamics of antigenic variation. Infect. Genet. Evol. 6 (2006) 141-146
113. Frank S.A., and Bush R.M. Barriers to antigenic escape by pathogens: trade-off between reproductive rate and antigenic mutability. BMC Evol. Biol. 7 (2007) 229
114. Frank S.A., and Schmid-Hempel P. Mechanisms of pathogenesis and the evolution of parasite virulence. J. Evol. Biol. 21 (2008) 396-404
115. Fraser C., Hollingsworth T.D., Chapman R., de Wolf F., and Hanage W.P. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 17441-17446
116. Fridkin S.K., Hageman J., McDougal L.K., Mohammed J., Jarvis W.R., Perl T.M., and Tenover F.C. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2000. Clin. Infect. Dis. 36 (2003) 429-439
117. Friedrich T.C., McDermott A.B., Reynolds M.R., Piaskowski S., Fuenger S., de Souza I.P., Rudersdorf R., Cullen C., Yant L.J., Vojnov L., Stephany J., Martin S., O'Connor D.H., Wilson N., and Watkins D.I. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naïve hosts. J. Virol. 78 (2004) 10064-10073
118. Gagneux S., DeRiemer K., Van T., Kato-Maeda M., de Jong B.C., Narayana S., Nicol M., Niemann S., Kremer K., Gutierrez M.C., Hilty M., Hopewell P.C., and Small P.M. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2869-2873
119. Gaidelyte A., Vaara M., and Bamford D.H. Bacteria, phages and septicemia. PLoS One 2 (2007) e1145
120. Gal-Mor O., Gibson D.L., Vallance B.A., and Finlay B.B. A novel secretion pathway of Salmonella enterica acts as an antivirulence modulator during salmonellosis. PLoS Pathog. 4 (2008) e1000036
121. Galvani A.P. Epidemiology meets evolutionary ecology. Trends Ecol. Evol. (2003)
122. Galvani A.P., and Novembre J. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Microbes Infect. 7 (2005) 302-309
123. Gandon S., and Day T. The evolutionary epidemiology of vaccination. J. R. Soc. Interface 4 (2007) 803-817
124. Gandon S., Mackinnon M.J., Nee S., and Read A.F. Imperfect vaccines and the evolution of pathogen virulence. Nature 414 (2001) 751-756
125. Ganusov V.V. Evolution of virulence: adaptive or not?. Trends Microbiol. 11 (2003) 112-113
126. Ganusov V.V., and Antia R. Trade-offs and the evolution of virulence of microparasites: do details matter?. Theor. Pop. Biol. (2003)
127. Geels M.J., Cornelissen M., SchuiteMaker H., Anderson K., Kwa D., Maas J., Dekker J.T., Baan E., Zorgdrager F., van den Burg R., van Beelen M., Lukashov V.V., Fu T.M., Paxton W.A., van der Hoek L., Dubey S.A., Shiver J.W., and Goudsmit J. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. J. Virol. 77 (2003) 12430-12440
128. Geenen P.L., Van der Meulen J., Bouma A., and De Jong M.C.M. Estimating transmission parameters of F4+ E. coli for F4-receptor-positive and -negative piglets: one-to-one transmission experiment. Epidemiol. Infect. 2004 (2004) 1039-1048
129. Gilchrist M.A., and Coombs D. Evolution of virulence: interdependence, constraints, and selection using nested models. Theor. Pop. Biol. 69 (2006) 145-153
130. Gog J., and Grenfell B.T. Dynamics and selection of many-strain pathogens. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 17209-17214
131. Gog J.R. The impact of evolutionary constraints on influenza dynamics. Vaccine 26 Suppl. 3 (2008) C15-C24
132. Goodman L.B., Loregian A., Perkins G.A., Nugent J., Buckles E.L., Mercorelli B., Kydd J.H., Palù G., Smith K.C., Osterreider N., and Davis-Poynter N. A point-mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog. 3 (2007) e160
133. Gorwitz R.J. Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community. J. Infect. Dis. 197 (2008) 179-182
134. Gould S.J., and Lewontin R.C. The spandrels of San Marco and the Panglossian paradigm: a critique of the adaptationist programme. Proc. R. Soc. Lond. B 205 (1979) 581-598
135. Goulder P.J.R., Brander C., Tang Y., Tremblay C., Colbert R.A., Addo M.M., Rosenberg E.S., Nguyen T., Allen R., Trocha A., Altfeld M., He S., Bunce M., Funkhouser R., Pelton S.I., Burchett S.K., McIntosh K., Korber B.T.M., and Walker B.D. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412 (2001) 334-338
136. Grant A.J., Restif O., McKinley T.J., Sheppard M., Maskell D.J., and Mastroeni P. Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLoS Biol. 6 (2008) e74
137. Grassly N.C., Garnett G.P., Schwartländer B., Gregson S., and Anderson R.M. The effectiveness of HIV prevention and the epidemiological context. Bull. World Health Org. 79 (2001) 1121-1132
138. Grech K., Chan B.H.K., Anders R.F., and Read A.F. The impact of immunization on competition within Plasmodium infections. Evolution 62 (2008) 2359-2371
139. Grenfell B.T., Pybus O.G., Gog J.R., Wood J.L.N., Daly J.M., Mumford J.A., and Holmes E.C. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303 (2004) 327-332
140. Guzman C.A., Borsutzky S., Griot-Wenk M., Metcalfe I.C., Pearman J., Collioud A., Favre D., and Dietrich G. Vaccines against typhoid fever. Vaccine 24 (2006) 3804-3811
141. Haller O., Staeheli P., and Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 89 (2007) 812-818
142. Hancock R.E.W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1 (2001) 156-164
143. Handel A., Longini I.M., and Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comput. Biol. 3 (2007) e240
144. Hastings I.M., and Donnelly M.J. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resist. Updat. 8 (2005) 43-50
145. Hayden F.G., Belshe R.B., Clover R.D., Hay A.J., Oakes M.G., and Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N. Engl. J. Med. 321 (1989) 1696-1702
146. Heeney J.L. Zoonotic viral diseases and the frontier of early diagnosis, control and prevention. J. Intern. Med. 260 (2006) 399-408
147. Heffernan J.M., and Keeling M.J. An in-host model of acute infection: measles as a case study. Theor. Pop. Biol. 73 (2008) 134-147
148. Hegreness M., Shoresh N., Damian D., Hartl D., and Kishony R. Accelerated evolution of resistance in multidrug environments. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 13977-13981
149. Hennig B.J., Fielding K., Broxholme J., Diatta M., Mendy M., Moore C., Pollard A.J., Rayco-Solon P., Sirugo G., van der Sande M.A., Waight P., Whittle H.C., Zaman S.M., Hill A.V., and Hall A.J. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One 3 (2008) e1898
150. Hentzer M., Wu H., Andersen J.B., Riedel K., Rasmussen T.B., Bagge N., Kumar N., Schembri M.A., Song Z., Kristoffersen P., Manefield M., Costerton J.W., Molin S., Eberl L., Steinberg P., Kjelleberg S., Høiby N., and Givskov M. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22 (2003) 3803-3815
151. Hiramatsu K., Cui L., Kuroda M., and Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9 (2001) 486-493
152. Hirst G.K. The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science 94 (1941) 22-23
153. Ho S.Y., Chua S.Q., Foo D.G.W., Locht C., Chow V.T., Poh C.L., and Alonso S. Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates. Infect. Immun. 76 (2008) 111-119
154. Hochberg M.E. Establishing genetic correlations involving parasite virulence. Evolution 52 (1998) 1865-1868
155. Holmes E.C., and Twiddy S.S. The origin, emergence and evolutionary genetics of dengue virus. Infect. Genet. Evol. 3 (2003) 19-28
156. Holt K.E., Parkhill J., Mazzoni C.J., Roumagnac P., Weill F.X., Goodhead I., Rance R., Baker S., Maskell D.J., Wain J., Dolecek C., Achtman M., and Dougan G. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat. Genet. 40 (2008) 987-993
157. Hsu H.Y., Chang M.-H., Liaw S.H., Ni Y.H., and Chen H.-L. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30 (1999) 1312-1317
158. Hutchings M.R., Knowler K.J., McAnulty R., and McEwan J.C. Genetically resistant sheep avoid parasites to a greater extent than do susceptible sheep. Proc. R. Soc. Lond. B 274 (2007) 1839-1844
159. Hyde J.E. Drug-resistant malaria. Trends Parasitol. 21 (2005) 494-498
160. Hyvönen P., Suojala L., Orro T., Haaranen J., Simola O., Rontved C., and Pyorala S. Transgenic cows that produce recombinant human lactoferrin in milk are not protected from experimental Escherichia coli intramammary infection. Infect. Immun. 74 (2006) 6206-6212
161. Jeffery K.J.M., and Bangham C.R.M. Do infectious diseases drive MHC diversity?. Microbes Infect. 2 (2000) 1335-1341
162. John J.F., and Rice L.B. The microbial genetics of antibiotic cycling. Infect. Control. Hosp. Epidemiol. 21 Suppl. (2000) S22-S31
163. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J.L., and Daszak P. Global trends in emerging infectious diseases. Nature 451 (2008) 990-994
164. Joo J., Gunny M., Cases M., Hudson P.J., Albert R., and Harvill E.T. Bacteriophage-mediated competition in Bordetella bacteria. Proc. R. Soc. Lond. B 273 (2006) 1843-1848
165. Kaminsky R., Ducray P., Jung M., Clover R.D., Rufener L., Bouvier J., Schorderet-weber S., Wenger A., Wieland-Berghausen S., Goebel T., Gauvry N., Pautrat F., Skripsky T., Froelich O., Komoin-Oka C., Westlund B., Sluder A., and Mäser P. A new class of anthelmintics effective against drug-resistant nematodes. Nature 452 (2008) 176-180
166. Karlsson A.C., Deeks S.G., Barbour J.D., Heiken B.D., Younger S.R., Hoh R., Lane M., Sällberg M., Ortiz G.M., Demarest J.F., Liegler T., Grant R.M., Martin J.N., and Nixon D.F. Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene. J. Virol. 77 (2003) 6743-6752
167. Karthigesu V.D., Allison L.M.C., Fergusson M., and Howard C.R. A hepatitis B variant found in the sera of immunised children induces a conformational change in the HBsAg "a" mutant. J. Med. Virol. 58 (1999) 346-352
168. Kimata J.T., Kuller L., Anderson D.B., Dailey P., and Overbaugh J. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat. Med. 5 (1999) 535-541
169. Kirupaharan N., and Allen L.J.S. Coexistence of multiple pathogen strains in stochastic epidemic models with density-dependent mortality. Bull. Math. Biol. 66 (2004) 841-864
170. Koella J.C., and Antia R. Epidemiological models for the spread of antimalarial resistance. Malaria J. 2 (2003) 3-13
171. Koelle K., Cobey S., Grenfell B.T., and Pascual M. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314 (2006) 1898-1903
172. Lackenby A., Hungnes O., Dudman S.G., Meijer A., Paget W.J., Hay A.J., and Zambon M. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill. 13 (2008) 8026
173. Lan R., and Reeves P.R. When does a clone deserve a name? A perspective on bacterial species based on population genetics. Trends Microbiol. 9 (2001) 419-424
174. Langhorne J., Ndungu F.M., Sponaas A.M., and Marsh K. Immunity to malaria: more questions than answers. Nat. Immunol. 9 (2008) 725-732
175. Lawley T.D., Bouley D.M., Hoy Y.E., Gerke C., Relman D.A., and Monack D.M. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect. Immun. 76 (2008) 403-416
176. Lell B., May J., Schmidt-Ott R.J., Lehman L.G., Luckner D., Greve B., Matousek P., Schmid D., Herbich K., Mockenhaupt F.P., Meyer C.G., Bienzle U., and Kremsner P.G. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin. Infect. Dis. 28 (1999) 794-799
177. Lenski R.E., and May R.M. The evolution of virulence in parasites and pathogens: reconciliation between two competing hypotheses. J. Theor. Biol. 169 (1994) 253-265
178. Levin B.R., and Antia R. Why we don't get sick: the within-host population dynamics of bacterial infections. Science 292 (2001) 1112-1115
179. Levin B.R., and Bull J.J. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2 (2004) 166-171
180. Levin B.R., Lipsitch M., and Bonhoeffer S. Population biology, evolution, and infectious disease: convergence and synthesis. Science 283 (1998) 806-809
181. Levin S.A., and Pimentel D. Selection of intermediate rates of increase in parasite-host systems. Am. Nat. 117 (1981) 308-315
182. Levy S.B., and Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10 (2004) S122-S129
183. Levy V., and Grant R.M. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Clin. Infect. Dis. 43 (2006) 904-910
184. Lipsitch M., Cohen T., Murray M., and Levin B.R. Antiviral resistance and the control of pandemic influenza. PLoS Med. 4 (2007) e15
185. Lipsitch M., and O'Hagan J.J. Patterns of antigenic diversity and the mechanisms that maintain them. J. R. Soc. Interface 4 (2007) 787-802
186. Liu C., Graber C.J., Karr M., An Diep B., Basuino L., Schwartz B.S., Enright M.C., O'Hanlon S.J., Thomas J.C., Perdreau-Remington F., Gordon S., Gunthorpe H., Jacobs R., Jensen P., Leoung G., Rumack J., and Chambers H.F. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin. Infect. Dis. 46 (2008) 1637-1646
187. Loh L., Petravic J., Batten C.J., Davenport M.P., and Kent S.J. Vaccination and timing influence SIV immune escape viral dynamics in vivo. PLoS Pathog. 4 (2008) e12
188. Luo N., Pereira S., Sahin O., Lin J., Huang S., Michel L., and Zhang Q. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 541-546
189. Lynch C., Pearce R., Pota H., Cox J., Abeku T.A., Rwakimara J., Naidoo I., Tibenderana J., and Roper C. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J. Infect. Dis. 197 (2008) 1598-1604
190. MacCallum C.J. Does medicine without evolution make sense?. PLoS Biol. 5 (2007) e112
191. Mackinnon M.J., Gaffney D.J., and Read A.F. Virulence in rodent malaria: host genotype by parasite genotype interactions. Infect. Genet. Evol. 1 (2002) 287-296
192. Mackinnon M.J., and Read A.F. Genetic relationships between parasite virulence and transmission in the rodent malaria Plasmodium chabaudi. Evolution 53 (1999) 689-703
193. Mackinnon M.J., and Read A.F. Immunity promotes virulence evolution in a malaria model. PLoS Biol. 2 (2004) e230
194. Mackinnon M.J., and Read A.F. Virulence in malaria: an evolutionary viewpoint. Philos. Trans. R. Soc. Lond. B 359 (2004) 965-986
195. Maga E.A., Shoemaker C.F., Rowe J.D., BonDurant R.H., Anderson G.B., and Murray J.D. Production and processing of milk from transgenic goats expressing human lysozyme in the mammary gland. J. Dairy Sci. 89 (2006) 518-524
196. Manning S.D., Motiwala A.S., Springman A.C., Qi W., Lacher D.W., Ouellette L.M., Mladonicky J.M., Somsel P., Rudrik J.T., Dietrich S.E., Zhang W., Swaminathan B., Alland D., and Whittam T.S. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 4868-4873
197. Marozin S., Gregory V., Cameron K., Bennett M., Valette M., Aymard M., Foni E., Barigazzi G., Lin Y.-C., and Hay A. Antigenic and genetic diversity among swine influenza A H1N1 and H1N2 viruses in Europe. J. Gen. Virol. 83 (2002) 735-745
198. Martcheva M., Bolker B.M., and Holt R.D. Vaccine-induced pathogen strain replacement: what are the mechanisms?. J. R. Soc. Interface 5 (2008) 3-13
199. Martin C., Williams A., Hernandez-Pando R., Cardona P.J., Gormley E., Bordat Y., Soto C.Y., Clark S.O., Hatch G.J., Aguilar D., Ausina V., and Gicquel B. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Vaccine 24 (2006) 3408-3419
200. Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., Pillay T., Rousseau C., Mullins J.I., Brander C., Walker B.D., Stuart D.I., Kiepiela P., and Goulder P. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80 (2006) 3617-3623
201. Martinez J.L., and Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44 (2000) 1771-1777
202. Mason R.D., Bowmer M.I., Howley C.M., Gallant M., Myers J.C.E., and Grant M.D. Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 pol epitopes. J. Immunol. 172 (2004) 7212-7219
203. Massey R.C., Buckling A., and Peacock S.J. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr. Biol. 11 (2001) 1810-1814
204. Matthews L., and Woolhouse M.E.J. New approaches to quantifying the spread of infection. Nat. Rev. Microbiol. 3 (2005) 529-537
205. May R.M., and Anderson R.M. Epidemiology and genetics in the coevolution of parasites and hosts. Proc. R. Soc. Lond. B 219 (1983) 281-313
206. Mazmanian S.K., Round J.L., and Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008) 620-625
207. McBride R., Greig D., and Travisano M. Fungal viral mutualism moderated by ploidy. Evolution 62 (2008) 2372-2380
208. McCuddin Z.P., Carlson S.A., Rasmussen M.A., and Franklin S.K. Klebsiella to Salmonella gene transfer within rumen protozoa: implications for antibiotic resistance and rumen defaunation. Vet. Microbiol. 114 (2006) 275-284
209. McDade J.E., and Anderson B.E. Molecular epidemiology: applications of nucleic acid amplification and sequence analysis. Epidemiol. Rev. 18 (1996) 90-97
210. McEwen S.A., and Fedorka-Cray P.J. Antimicrobial use and resistance in animals. Clin. Infect. Dis. 34 Suppl. 3 (2002) S93-S106
211. McKenzie F.E. Smallpox models as policy tools. Emerg. Infect. Dis. 10 (2004) 2044-2047
212. Merrel D.S., and Falkow S. Frontal and stealth attack strategies in microbial pathogenesis. Nature 430 (2004) 250-256
213. Mideo N., and Day T. On the evolution of reproductive restraint in malaria. Proc. R. Soc. Lond. B 275 (2008) 1217-1224
214. Milinski M. The major histocompatibility complex, sexual selection, and mate choice. Annu. Rev. Ecol. Evol. Syst. 37 (2006) 159-186
215. Mölstad S., Erntell M., Hanberger H., Melander E., Norman C., Skoog G., Stalsby Lundborg C., Söderström A., Torell E., and Cars O. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect. Dis. 8 (2008) 125-132
216. Monot M., Honoré N., Garnier T., Araoz R., Coppée J.Y., Lacroix C., Sow S., Spencer J.S., Truman R.W., Williams D.L., Gelber R., Virmond M., Flageul B., Cho S.N., Ji B., Paniz-Mondolfi A., Convit J., Young J., Fine P.E., Rasolofo V., Brennan P.J., and Cole S.T. On the origin of leprosy. Science 308 (2005) 1040-1042
217. Moriya C., Igarashi H., Takeda A., Tsukamoto T., Kawada M., Yamamoto H., Inoue M., Iida A., Shu T., Hasegawa M., Nagai Y., and Matano T. Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences. Microbes Infect. 10 (2008) 285-292
218. Mueller S.M., Schaetz B., Eismall K., Bergmann S., Bauerle M., Schmitt-Haendle M., Walter H., Schmidt B., Korn K., Sticht H., Spriewald B., Harrer E.G., and Harrer T. Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease. J. Virol. 81 (2007) 2887-2898
219. Müller V., et al. Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS 20 (2006) 889-894
220. Murdoch W.W., Chesson J., and Chesson P.L. Biological control in theory and practice. Am. Nat. 125 (1985) 344-366
221. Murphy R.A. The emerging crisis of drug-resistant tuberculosis in South Africa: lessons from New York City. Clin. Infect. Dis. 46 (2008) 1729-1732
222. Nakamura M.M., Liew S.Y., Cummings C.A., Brinig M.M., Dieterich C., and Relman D.A. Growth phase- and nutrient limitation-associated transcript abundance regulation in Bordetella pertussis. Infect. Immun. 74 (2006) 5537-5548
223. Napravnik S., Keys J.R., Quinlivan E.B., Wohl D.A., Mikeal A.V., and Eron J.J. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients. AIDS 21 (2007) 825-834
224. Nath M., Wooliams J.A., and Bishop S.C. Identifying critical parameters in the dynamics and control of microparasite infection using a stochastic epidemiological model. J. Anim. Sci. 82 (2004) 384-396
225. Navarathna D.H.M.L.P., Hornby J.M., Hoerrmann N., Parkhurst A.M., Duhamel G.E., and Nickerson K.W. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. J. Antimicrob. Chemother. 56 (2005) 1156-1159
226. Nesse R.M., and Stearns S.C. The great opportunity: evolutionary applications to medicine and public health. Evol. Appl. 1 (2008) 28-48
227. Nkhoma S., Molyneux M., and Ward S. In vitro antimalarial susceptibility profile and pfcrt/pfmdr-1 genotypes of Plasmodium falciparum field isolates from Malawi. Am. J. Trop. Med. Hyg. 76 (2007) 1107-1112
228. Owens R.C., Donskey C.J., Gaynes R.P., Loo V.G., and Muto C.A. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin. Infect. Dis. 46 (2008) S19-S31
229. Palumbi S.R. Humans as the world's greatest evolutionary force. Science 293 (2001) 1786-1790
230. Park A.W., Wood J.L.N., Daly J.M., Newton J.R., Glass K., Henley W., Mumford J.A., and Grenfell B.T. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population. Proc. R. Soc. Lond. B 271 (2004) 1547-1555
231. Parker M.M., Gordon D., Reilly A., Horowitz H.W., Waters M., Bennett R., Hallack R., Smith J., Lamson D., Aydemir A., Dvali N., Agins B.D., Drusano G.L., and Taylor J. Prevalence of Drug-Resistant and Nonsubtype B HIV Strains in Antiretroviral-Naïve, HIV-Infected Individuals in New York State. AIDS Patient Care STDS 21 (2007) 644-652
232. Pasteur L. Sur les maladies virulentes, et en particulier sur la maladie appelée vulgairement choléra des poules. C. R. Hebd. Seances Acad. Sci. 90 (1880) 239-248
233. Pereira L., Cassai E., Honess R.W., Roizman B., Terni M., and Nahmias A. Variability in the structural polypeptides of herpes simplex virus 1 strains: potential application in molecular epidemiology. Infect. Immun. 13 (1976) 211-220
234. Pereyra F., Addo M.M., Kaufmann D.E., Liu Y., Miura T., Rathod A., Baker B., Trocha A., Rosenberg R., Mackey E., Ueda P., Lu Z., Cohen D., Wrin T., Petropoulos C.J., Rosenberg E.S., and Walker B.D. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197 (2008) 563-571
235. Perron G.G., Gonzalez A., and Buckling A. Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. Proc. R. Soc. Lond. B 274 (2007) 2351-2356
236. Perron G.G., Zasloff M., and Bell G. Experimental evolution of resistance to an antimicrobial peptide. Proc. R. Soc. Lond. B 273 (2006) 251-256
237. Peterson K.M. Expression of Vibrio cholerae virulence genes in response to environmental signals. Curr. Issues Intest. Microbiol. 3 (2002) 29-38
238. Peyerl F.W., Bazick H.S., Newberg M.H., Barouch D.H., Sodroski J., and Letvin N.L. Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope. J. Virol. 78 (2004) 13901-13910
239. Pomeroy L.W., Bjørnstad O.N., and Holmes E.C. The evolutionary and epidemiological dynamics of the paramyxoviridae. J. Mol. Evol. 66 (2008) 98-106
240. Porco T.C., Lloyd-smith J.O., Gross K.L., and Galvani A.P. The effect of treatment on pathogen virulence. J. Theor. Biol. 233 (2005) 91-102
241. Proctor R.A., von Eiff C., Kahl B.C., Becker K., McNamara P., Herrmann M., and Peters G. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4 (2006) 295-305
242. Prugnolle F., Manica A., Charpentier M., Guégan J.-F., Guernier V., and Balloux F. Pathogen-driven selection and worldwide HLA class I diversity. Curr. Biol. 15 (2005) 1022-1027
243. Ragon M., Wirth T., Hollandt F., Lavenir R., Lecuit M., Le Monnier A., and Brisse S. A new perspective on Listeria monocytogenes evolution. PLoS Pathog. 4 (2008) e1000146
244. Rahman M., Matthijnssens J., Yang X., Delbeke T., Arijs I., Taniguchi K., Iturriza-Gomara M., Iftekharuddin N., Azim T., and Van Ranst M. Evolutionary history and global spread of the emerging g12 human rotaviruses. J. Virol. 81 (2007) 2382-2390
245. Rameix-Welti M.A., Enouf V., Cuvelier F., Jeannin P., and van der Werf S. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog. 4 (2008) e1000103
246. Ray N., Harrison J.E., Blackburn L.A., Martin J.N., Deeks S.G., and Doms R.W. Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors. J. Virol. 81 (2007) 3240-3250
247. Razavi B., Apisarnthanarak A., and Mundy L.M. Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection 35 (2007) 300-307
248. Read J.M., and Keeling M.J. Stochasticity generates an evolutionary instability for infectious disease. Ecol. Lett. 10 (2007) 818-827
249. Regoes R.R., and Bonhoeffer S. Emergence of drug-resistant influenza virus: population dynamical considerations. Science 312 (2006) 389-391
250. Restif O., and Grenfell B.T. Integrating life history and cross-immunity into the evolutionary dynamics of pathogens. Proc. R. Soc. Lond. B 273 (2006) 409-416
251. Restif O., and Grenfell B.T. Vaccination and the dynamics of immune evasion. J. R. Soc. Interface 4 (2007) 143-153
252. REX Consortium. Structure of the scientific community modelling the evolution of resistance. PLoS One 2 (2007) e1275
253. Ribes S., Taberner F., Cabellos C., Tubau F., Ardanuy C., Gerber J., Liñares J., Nau R., and Gudiol F. Contribution of capsular and clonal types and β-lactam resistance to the severity of experimental pneumococcal meningitis. Microbes Infect. 10 (2008) 129-134
254. Richman D.D. Antiviral drug resistance. Antiviral Res. 71 (2006) 117-121
255. Rogers T.R. Antifungal drug resistance: limited data, dramatic impact?. Int. J. Antimicrob. Agents 27 Suppl. 1 (2006) 7-11
256. Romano J., Nimrod G., Ben-Tal N., Shadkchan Y., Baruch K., Sharon H., and Osherov N. Disruption of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence. Microbiology 152 (2006) 1919-1928
257. Rosvall M., and Bergstrom C.T. Maps of random walks on complex networks reveal community structure. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 1118-1123
258. Roumagnac P., Weill F.X., Dolecek C., Baker S., Brisse S., Chinh N.T., Le T.A., Acosta C.J., Farrar J., Dougan G., and Achtman M. Evolutionary history of Salmonella Typhi. Science 314 (2006) 1301-1304
259. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., Gust I.D., Hampson A.W., Hay A.J., Hurt A.C., De Jong J.C., Kelso A., Klimov A.I., Kageyama T., Komadina N., Lapedes A.S., Lin Y.P., Mosterin A., Obuchi M., Odagiri T., Osterhaus A.D.M.E., Rimmelzwaan G.F., Shaw M.W., Skepner E., Stohr K., Tashiro M., Fouchier R.A.M., and Smith D.J. The global circulation of seasonal influenza A (H3N2) viruses. Science 320 (2008) 340-346
260. Sabeti P.C., Walsh E., Schaffner S.F., Varilly P., Fry B., Hutcheson H.B., Cullen M., Mikkelsen T.S., Roy J., Patterson H.B., Cooper R., Reich D., Altshuler D., O'Brien S., and Lander E.S. The case for selection at CCR5-Delta32. PLoS Biol. 3 (2005) e378
261. Sacchettini J.C., Rubin E.J., and Freundlich J.S. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat. Rev. Microbiol. 4 (2008) 41-52
262. Salk J.E., and Suriano P.C. Importance of antigenic composition of influenza virus vaccine in protecting against the natural disease: observations during the winter of 1947-1948. Am. J. Publ. Health Nations Health 39 (1949) 345-355
263. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin C.P., and Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med. 14 (2008) 407-412
264. Scandurra G.M., Britton W.J., and Triccas J.A. Inactivation of the Mycobacterium tuberculosis fadB4 gene results in increased virulence in host cell and mice. Microbes Infect. 10 (2008) 38-44
265. Schmid-Hempel P., and Ebert D. On the evolutionary ecology of specific immune defence. Trends Ecol. Evol. 18 (2003) 27-32
266. Shekelle P., Maglione M., Geotz M.B., Wagner G., Wang Z., Hilton L., Carter J., Chen S., Tringle C., Mojica W., and Newberry S. Antiretroviral (ARV) drug resistance in the developing world. Evidence Report/Technol. Assess. 156 (2007) 1-74
267. Sheng H., Knecht H.J., Kudva I.T., and Hovde C.J. Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants. Appl. Environ. Microbiol. 72 (2006) 5359-5366
268. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D.M.E., and Fouchier R.A.M. Mapping the antigenic and genetic evolution of influenza virus. Science 305 (2004) 371-376
269. Smith P.A., and Romesberg F.E. Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation. Nat. Chem. Biol. 3 (2007) 549-556
270. Smith T. Imperfect vaccines and imperfect models. Trends Ecol. Evol. 17 (2002) 154-156
271. Stabler R.A., Gerding D.N., Songer J.G., Drudy D., Brazier J.S., Trinh H.T., Witney A.A., Hinds J., and Wren B.W. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J. Bacteriol. 188 (2006) 7297-7305
272. Stearns S.C., and Koella J.C. Evolution in Health and Disease (2007)
273. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., Chaffron S., Macpherson A.J., Buer J., Parkhill J., Dougan G., von Mering C., and Hardt W.D. Salmonella enterica serovar Typhimurium exploits host inflammation to compete with the intestinal microbiota. PLoS Biol. 5 (2007) e244
274. Stollenwerk N., Maiden M.C.J., and Jansen V.A.A. Diversity in pathogenicity can cause outbreaks of meningococcal disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10229-10234
275. Szmaragd C., Foster G.R., Manica A., Bartholomeusz A., Nichols R.A., and Balloux F. Genome-wide characterisation of Hepatitis B mutations involved in clinical outcome. Heredity 97 (2006) 389-397
276. Takala S.L., Coulibaly D., Thera M.A., Dicko A., Smith D.L., Guindo A.B., Kone A.K., Traore K., Ouattara A., Djimde A.A., Sehdev P.S., Lyke K.E., Diallo D.A., Doumbo O.K., and Plowe C.V. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Med. 4 (2007) e93
277. Temime, L., Hejblum, G., Setbon, M., Valleron, A.J., 2008. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study. Epidemiol. Infect. 136, 289-298.
278. Terry B.T. An attenuated surra of Mauritius with immunity tests after recovery. J. Exp. Med. 12 (1910) 176-181
279. Thomson M.M., Pérez-Álvarez L., and Nájera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect. Dis. 2 (2002) 461-471
280. Tibayrenc M. Beyond strain typing and molecular epidemiology: integrated genetic epidemiology of infectious diseases. Parasitol. Today 14 (1998) 323-329
281. Topley W.W.C. The spread of bacterial infection. Some characteristics of long-continued epidemics. J. Hyg. 19 (1921) 350-379
282. Traub R.J., Monis P.T., and Robertson I.D. Molecular epidemiology: a multidisciplinary approach to understanding parasitic zoonoses. Int. J. Parasitol. 35 (2005) 1295-1307
283. Tumpey T.M., Szretter K.J., Van Hoeven N., Katz J.M., Kochs G., Haller O., García-Sastre A., and Staeheli P. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J. Virol. 81 (2007) 10818-10821
284. UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study and UK Register of HIV Seroconverters, 2007. Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom. AIDS 21, 1035-1039.
285. van Baalen M., and Sabelis M.W. The scope for virulence management: a comment on Ewald's view on the evolution of virulence. Trends Microbiol. 3 (1995) 414-416
286. van Ballegooijen W.M., and Boerlijst M.C. Emergent trade-offs and selection for outbreak frequency in spatial epidemics. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 18246-18250
287. Van Bambeke F., Mingeot-Leclercq M.P., Struelens M.J., and Tulkens P.M. The bacterial envelope as a target for novel anti-MRSA antibiotics. Trends Pharmacol. Sci. 29 (2008) 124-134
288. van Loon H.J., Vriens M.R., Fluit A.C., Troelstra A., van der Werken C., Verhoef J., and Bonten M.J.M. Antibiotic rotation and development of gram-negative antibiotic resistance. Am. J. Respir. Crit. Care Med. 171 (2005) 480-487
289. Vignuzzi M., Wendt E., and Andino R. Engineering attenuated virus vaccines by controlling replication fidelity. Nat. Med. 14 (2008) 154-161
290. Vlaminckx B.J., Schuren F.H., Montijn R.C., Caspers M.P., Beitsma M.M., Wannet W.J., Schouls L.M., Verhoef J., and Jansen W.T. Dynamics in prophage content of invasive and noninvasive M1 and M28 Streptococcus pyogenes isolates in The Netherlands from 1959 to 1996. Infect. Immun. 75 (2007) 2673-3679
291. Wall R.J., Powell A.M., Paape M.J., Kerr D.E., Bannerman D.D., Pursel V.G., Wells K.D., Talbot N., and Hawk H.W. Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat. Biotechnol. 23 (2005) 445-451
292. Walther B.A., and Ewald P.W. Pathogen survival in the external environment and the evolution of virulence. Biol. Rev. 79 (2004) 1-21
293. Wang C., Li M., Dong D., Wang J., Ren J., Otto M., and Gao Q. Role of ClpP in biofilm formation and virulence of Staphylococcus epidermidis. Microbes Infect. 9 (2007) 1376-1383
294. Wearing H.J., and Rohani P. Ecological and immunological determinants of dengue epidemics. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11802-11807
295. Webby R.J., and Webster R.G. Emergence of influenza A viruses. Philos. Trans. R. Soc. Lond. B 356 (2001) 1817-1828
296. Webster L.T. The application of experimental methods to epidemiology. Am. J. Epidemiol. 4 (1924) 134-142
297. Webster R.G., and Laver W.G. Studies on the origin of pandemic influenza I. Antigenic analysis of A2 influenza viruses isolated before and after the appearance of Hong Kong influenza using antisera to the isolated hemagglutinin subunits. Virology 48 (1972) 433-444
298. Wells C.D., Cegielski J.P., Nelson L.J., Laserson K.F., Holtz T.H., Finlay A., Castro K.G., and Weyer K. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J. Infect. Dis. 196 Suppl. 1 (2007) S86-S107
299. White N.J. Antimalarial drug resistance. J. Clin. Invest. 113 (2004) 1084-1092
300. Wongsrichanalai C., and Meshnick S.R. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg. Infect. Dis. 14 (2008) 716-719
301. Woodford N., and Ellington M.J. The emergence of antibiotic resistance by mutation. Clin. Microbiol. Infect. 13 (2007) 5-18
302. Wright G.D. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 5 (2007) 175-186
303. Yerly S., et al. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS 21 (2007) 2223-2229
304. Young J.F., Desselberger U., and Palese P. Evolution of human influenza A viruses in nature: sequential mutations in the genomes of new H1N1. Cell 18 (1979) 73-83
305. Young J.F., and Palese P. Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 strains. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 6547-6551
306. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
307. Zawicki P., and Witas H.W. HIV-1 protecting CCR5-Δ32 allele in medieval Poland. Infect. Genet. Evol. 8 (2008) 146-151
308. Zhang K., McClure J.-A., Elsayed S., Tan J., and Conly J.M. Coexistence of Panton-Valentine leukocidin -positive and - negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region. J. Infect. Dis. 197 (2008) 195-204